Knowledge, attitudes and perspective on adverse drug reaction reporting in a public sector hospital in South Africa: baseline analysis

References

• Mehta UC. Pharmacovigilance: the devastating consequences of not thinking about adverse drug reactions. The burden of adverse drug reactions (ADRs) on patient care has been found to be high globally and is particularly high in South Africa. CME. 2011;29(6):247–251.
   Google Scholar
• Rehan HS, Chopra D, Kakkar AK. Physician’s guide to pharmacovigilance: terminology and causality assessment. Eur J Intern Med. 2009;20(1):3–8.
   PubMed Web of Science ®Google Scholar
• Vessal G, Mardani Z, Mollai M. Knowledge, attitudes, and perceptions of pharmacists to adverse drug reaction reporting in Iran. Pharm World Sci. 2009;31(2):183–187.
   PubMedGoogle Scholar
• Shamim S, Sharib SM, Malhi SM, et al. Adverse drug reactions (ADRS) reporting: awareness and reasons of under-reporting among health care professionals, a challenge for pharmacists. SpringerPlus. 2016;5(1):1778.
   PubMedGoogle Scholar
• Mouton JP, Mehta U, Parrish AG, et al. Mortality from adverse drug reactions in adult medical inpatients at four hospitals in South Africa: a cross-sectional survey. Br J Clin Pharmacol. 2015;80(4):818–826.
   PubMed Web of Science ®Google Scholar
• Wiktorowicz M, Lexchin J, Moscou K. Pharmacovigilance in Europe and North America: divergent approaches. Soc Sci Med. 2012;75(1):165–170.
   PubMed Web of Science ®Google Scholar
• Kiguba R, Karamagi C, Bird SM. Incidence, risk factors and risk prediction of hospital-acquired suspected adverse drug reactions: a prospective cohort of Ugandan inpatients. BMJ Open. 2017;7(1):e010568.
   PubMed Web of Science ®Google Scholar
• Jemal A, Ward E, Hao Y, et al. Trends in the leading causes of death in the United States, 1970-2002. JAMA. 2005;294(10):1255–1259.
   PubMed Web of Science ®Google Scholar
• Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA. 1998;279(15):1200–1205.
   PubMed Web of Science ®Google Scholar
• Pirmohamed M, James S, Meakin S, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. Br Med J. 2004;329(7456):15–19.
   PubMed Web of Science ®Google Scholar
• Brvar M, Fokter N, Bunc M, et al. The frequency of adverse drug reaction related admissions according to method of detection, admission urgency and medical department specialty. BMC Clin Pharmacol. 2009;9:8.
   PubMedGoogle Scholar
• Tumwikirize WA, Ogwal-Okeng JW, Vernby A, et al. Adverse drug reactions in patients admitted on Internal Medicine wards in a district and Regional Hospital in Uganda. Afr Health Sci. 2011;11(1):72–78.
   PubMed Web of Science ®Google Scholar
• Godman B, Finlayson AE, Cheema PK, et al. Personalizing health care: feasibility and future implications. BMC Med. 2013;11:179.
   PubMed Web of Science ®Google Scholar
• Wu T-Y, Jen M-H, Bottle A, et al. Ten-year trends in hospital admissions for adverse drug reactions in England 1999–2009. J R Soc Med. 2010;103(6):239–250.
   PubMed Web of Science ®Google Scholar
• Veeren JC, Weiss M. Trends in emergency hospital admissions in England due to adverse drug reactions: 2008–2015. J Pharm Health Serv Res. 2017;8:5–11.
   Google Scholar
• Davies EC, Green CF, Taylor S, et al. Adverse drug reactions in hospital in-patients: a prospective analysis of 3695 patient-episodes. PloS One. 2009;4(2):e4439.
   PubMed Web of Science ®Google Scholar
• Mehta U, Durrheim DN, Blockman M, et al. Adverse drug reactions in adult medical inpatients in a South African hospital serving a community with a high HIV/AIDS prevalence: prospective observational study. Br J Clin Pharmacol. 2008;65(3):396–406.
   PubMed Web of Science ®Google Scholar
• Kiguba R, Waako P, Ndagije HB, et al. Medication error disclosure and attitudes to reporting by healthcare professionals in a sub-Saharan African setting: a survey in Uganda. Drugs - Real World Outcomes. 2015;2(3):273–287.
   PubMedGoogle Scholar
• Lopez-Gonzalez E, Herdeiro MT, Pineiro-Lamas M, et al. Effect of an educational intervention to improve adverse drug reaction reporting in physicians: a cluster randomized controlled trial. Drug Saf. 2015;38(2):189–196.
   PubMed Web of Science ®Google Scholar
• Lopez-Gonzalez E, Herdeiro MT, Figueiras A. Determinants of under-reporting of adverse drug reactions: a systematic review. Drug Saf. 2009;32(1):19–31.
   PubMed Web of Science ®Google Scholar
• Hazell L, Shakir SA. Under-reporting of adverse drug reactions: a systematic review. Drug Saf. 2006;29(5):385–396.
   PubMed Web of Science ®Google Scholar
• Sabblah GT, Akweongo P, Darko D, et al. Adverse drug reaction reporting by doctors in a developing country: a case study from Ghana. Ghana Med J. 2014;48(4):189–193.
   PubMedGoogle Scholar
• Suleman F. Pharmacovigilance – who is responsible and why should we care? SA Pharm J. 2010 October;2010:56–58.
   Google Scholar
• Mouton JP, Njuguna C, Kramer N, et al. Adverse drug reactions causing admission to medical wards: a cross-sectional survey at 4 hospitals in South Africa. Medicine. 2016;95(19):e3437.
   PubMed Web of Science ®Google Scholar
• Ribeiro-Vaz I, Santos C, Da Costa-Pereira A, et al. Promoting spontaneous adverse drug reaction reporting in hospitals using a hyperlink to the online reporting form: an ecological study in Portugal. Drug Saf. 2012;35(5):387–394.
   PubMed Web of Science ®Google Scholar
• Birbal S, Dheda M, Ojewole E, et al. Adverse drug reactions associated with antiretroviral therapy in South Africa. Ajar. 2016;15(3):243–248.
   Google Scholar
• UMC. Uppsala Monitoring Centre. ANNUAL REPORT July 2015 - June 2016. Available from: https://www.who-umc.org/media/3081/umc-annual-report-final-version_small.pdf
   Google Scholar
• Ampadu HH, Hoekman J, De Bruin ML, et al. Adverse drug reaction reporting in Africa and a comparison of individual case safety report characteristics between Africa and the rest of the world: analyses of spontaneous reports in VigiBase®. Drug Saf. 2016;39(4):335–345.
   PubMed Web of Science ®Google Scholar
• Malladi P, Study A. Of adverse drug reactions reported to the adverse drug reaction monitoring centre at a Tertiary Care Teaching Hospital, Kuppam. World J Pharm Pharm Sci. 2016;5(10):804–812.
   Google Scholar
• MCC. Medicines control council South Africa. [cited 2017 Jun 20]. Available from: http://www.mccza.com/about/
   Google Scholar
• MCC. Medicines Control Council and National Department of Health. Reporting adverse drug reactions in South Africa. [cited 2017 Jun 18]. Available from: http://docplayer.net/37893933-Medicines-control-council.html
   Google Scholar
• Gauteng Province. Gauteng pharmacovigilance bulletin. 2017 Apr. [cited 2017 Jun 20]. Available from: file:///C:/Users/mail/Downloads/PV%20Bulletin%2020%20April.pdf
   Google Scholar
• NDOH. South African National Department of Health. Government gazette, 4 January 2017. Norms and standards regulations applicable to different categories of health establishments. [cited 2017 Jun 20]. Available from: http://www.samed.org.za/Filemanager/userfiles/national-health-act-61-2003-norms-and-standards-regulations-applicable-to-different-categories-of-health-establishments_20170104-GGN-40539-00010.pdf
   Google Scholar
• NDOH. National core standards for health establishments in South Africa. National Department of Health 2011. [cited 2017 Jun 4]. Availale from: http://www.rhap.org.za/wp-content/uploads/2014/05/National-Core-Standards-2011-1.pdf
   Google Scholar
• Ruud KW, Srinivas SC, Toverud EL. Addressing gaps in pharmacovigilance practices in the antiretroviral therapy program in the Eastern Cape Province, South Africa. Res Soc Admin Pharmacy. 2010;6(4):345–353.
   PubMed Web of Science ®Google Scholar
• Maigetter K, Pollock AM, Kadam A, et al. Pharmacovigilance in India, Uganda and South Africa with reference to WHO’s minimum requirements. Int J Health Policy Manage. 2015;4(5):295–305.
   PubMed Web of Science ®Google Scholar
• Joubert MC, Naidoo P. Knowledge, perceptions and practices of pharmacovigilance amongst community and hospital pharmacists in a selected district of North West Province, South Africa. Health SA Gesondheid. 2016;21:238–244.
   Google Scholar
• Nlooto M, Sartorius B. Differences in awareness and practice about adverse event reporting among doctors, nurses, pharmacists and post-basic pharmacist assistants in HIV clinical practice in the eThekwini Metropolitan Health district, South Africa. Botswana J Afr Stud. 2014;28(1):1–15.
   Google Scholar
• Dheda M, Kambafwile H, Oosthuizen F, et al. A cross-sectional baseline assessment of the pharmacovigilance systems, processes and challenges faced by healthcare professionals in three South African districts prior to pharmacovigilance training and programme roll-out. Botswana J Afr Stud. 2016;30(1):1–12.
   Google Scholar
• Khalili H, Mohebbi N, Hendoiee N, et al. Improvement of knowledge, attitude and perception of healthcare workers about ADR, a pre- and post-clinical pharmacists’ interventional study. BMJ Open. 2012;2(1):e000367.
   PubMed Web of Science ®Google Scholar
• Rajesh R, Vdyasagar S, Varma DM. An educational intervention to assess knowledge attitude practice of pharmacovigilance among Health care professionals in an Indian tertiary care teaching hospital. Int J PharmTech Res. 2011;3(2):678–692.
   Google Scholar
• Baniasadi S, Habibi M, Haghgoo R, et al. Increasing the number of adverse drug reactions reporting: the role of clinical pharmacy residents. Iran J Pharm Res. 2014;13(1):291–297.
   PubMed Web of Science ®Google Scholar
• WHO. The importance of pharmacovigilance: safety monitoring of medicinal products. [cited 2017 Jun 5]. Available from: http://whqlibdoc.who.int/hq/2002/a75646.pdf
   Google Scholar
• Eland IA, Belton KJ, Van Grootheest AC, et al. Attitudinal survey of voluntary reporting of adverse drug reactions. Br J Clin Pharmacol. 1999;48(4):623–627.
   PubMed Web of Science ®Google Scholar
• Katusiime B, Semakula D, Lubinga SJ. Adverse drug reaction reporting among health care workers at Mulago National Referral and Teaching hospital in Uganda. Afr Health Sci. 2015;15(4):1308–1317.
   PubMed Web of Science ®Google Scholar
• Wadagbalkar PTV, Raipurkar S. Knowledge, attitude and practice of interns regarding pharmacovigilance in a tertiary hospital of Madhya Pradesh. J Adv Med Dent Scie Re. 2016;4(6):216–219.
   Google Scholar
• Evans SM, Berry JG, Smith BJ, et al. Attitudes and barriers to incident reporting: a collaborative hospital study. Qual Saf Health Care. 2006;15(1):39–43.
   PubMedGoogle Scholar
• Fletcher AP. Spontaneous adverse drug reaction reporting vs event monitoring: a comparison. J R Soc Med. 1991;84(6):341–344.
   PubMed Web of Science ®Google Scholar
• Gony M, Badie K, Sommet A, et al. Improving adverse drug reaction reporting in hospitals: results of the French Pharmacovigilance in Midi-Pyrenees region (PharmacoMIP) network 2-year pilot study. Drug Saf. 2010;33(5):409–416.
   PubMed Web of Science ®Google Scholar
• Al-Arifi MN, Mayet A, Wajid S, et al. Knowledge, attitude and perception of physicians towards adverse drug reaction reporting at King Khalid University Hospital, Riyadh, Saudi Arabia. Trop J Pharm Res. 2015;14(5):907–911.
   Web of Science ®Google Scholar
• Toklu HZ, Uysal MK. The knowledge and attitude of the Turkish community pharmacists toward pharmacovigilance in the Kadikoy district of Istanbul. Pharm World Sci. 2008;30(5):556–562.
   PubMedGoogle Scholar
• MCC. Medicines Control Council. Post-marketing reporting of adverse drug reactions to human medicines in South Africa. [cited 2017 Jun 5]. Available from: http://www.mccza.com/documents/f39361792.33_ADR_reporting_post-marketing_Jul16_v4.1_showing_changes.pdf
   Google Scholar
• Herdeiro MT, Ribeiro-Vaz I, Ferreira M, et al. Workshop- and telephone-based interventions to improve adverse drug reaction reporting: a cluster-randomized trial in Portugal. Drug Saf. 2012;35(8):655–665.
   PubMed Web of Science ®Google Scholar
• Figueiras A, Herdeiro MT, Polonia J, et al. An educational intervention to improve physician reporting of adverse drug reactions: a cluster-randomized controlled trial. JAMA. 2006;296(9):1086–1093.
   PubMed Web of Science ®Google Scholar